USSubmitted label - approval not established

MD SCIENCE CANNABIGEROL (LIDOCAINE AND HISTAMINE DIHYDROCHLORIDE) CREAM

This is a locally preserved regulatory record. Source labeling does not by itself prove efficacy for a condition.

Submitted product label. A product label is preserved locally, but approval or current marketing status is not established.

Product data

Locally preserved regulatory fields

Active ingredients: cannabigerol, Lidocaine, Histamine Dihydrochloride
Route: Not reported
Dosage form: Not reported
Marketing holder: MD NATURAL HEALTH LLC
Catalog status: Submitted label - approval not established
Source-reported status: Not reported

Linked local records

Related local records

Substance links use source-reported active ingredients. Condition links come from registered study context and are not efficacy claims.

Cannabinoids and active compounds

cannabigerol Histamine

Condition reports

Migraine Disorders

Regulatory record

Approval, patents and exclusivity

Patent and exclusivity fields are preserved from the regulator. They are not a legal opinion and are separate from clinical development.

0approval records

0source-reported patents

0exclusivity records

Clinical development

Related registered studies

Phases and statuses are source-reported study stages matched by governed token phrases. They do not prove medicine identity, approval or efficacy.

8candidate study links

EARLY_PHASE1NOT_YET_RECRUITING

The Effects of Cannabis on Post Operative Recovery After Radical Cystectomy

DRUG · Cannabigerol

Non-metastatic Bladder Cancer

PHASE1COMPLETED

Acute Effects of Cannabigerol (CBG) on Mood and Cognition

DRUG · Cannabigerol

Focus: To Examine Acute Effects of CBG on Anxiety, Stress, and Cognition

PHASE2RECRUITING

CBG and Attention: A Double-Blind, Randomized, Placebo-Controlled Trial Examining the Effects of Cannabigerol on Indicators of Attention-Deficit/Hyperactivity Disorder

DRUG · Cannabigerol

Attention-Deficit/Hyperactivity Disorder

PHASE2COMPLETED

Trigger Point Injection in Reducing Pain Following Total Knee Arthroplasty

DRUG · Trigger point injection (lidocaine)

Trigger Point Pain, Myofascial

NACOMPLETED

Efficacy and Safety of Hemp-derived, Full Spectrum Cannabigerol (CBG) in Adults

OTHER · Cannabigerol

Health, Subjective · Inflammatory Response · Adverse Effect · Side Effect

PHASE2 · PHASE3TERMINATED

Randomized, Double Blind Clinical Trial to Study the Effect of Cannabidiol (CBD) 133mg + Cannabigerol (CBG) 66mg + Tetrahydrocannabinol (THC) 4mg a Day As Adjunctive Therapy in the Treatment of Chronic Migraine - CAMTREA TRIAL

DRUG · Cannabidiol + Cannabigerol + Tetrahydrocannabinol 133/66/4mg

Chronic Migraine, Headache · Overuse Headache Medication

NAACTIVE_NOT_RECRUITING

A Clinical Study to Assess the Efficacy of Cannabigerol in Patients with Active Rheumatoid Arthritis.

DIETARY_SUPPLEMENT · Cannabigerol (CBG)

Rheumatoid Arthritis · Inflammatory Disease

NACOMPLETED

A Placebo-controlled, Triple-blind, Pre-post Interventional Study of Swallowable Cannabigerol Tablets on Sleep Quality in Veterans

Source-reported use

Indications in regulatory records

No indication text was reported by the connected sources.

Medicine identity matching

RxNorm candidates

RxNorm normalizes identity; FAERS supplies non-causal post-market signals.

Identity candidate · score 9.97606282567978

RxNorm concept

Matched from: Lidocaine

Official RxNorm record

Identity candidate · score 15.872822407313757

histamine dihydrochloride / menthol Topical Cream [Alo]

Matched from: MD SCIENCE CANNABIGEROL (LIDOCAINE AND HISTAMINE DIHYDROCHLORIDE) CREAM

Official RxNorm record

Identity candidate · score 14.170814303379013

histamine dihydrochloride / menthol Topical Product

Matched from: Histamine Dihydrochloride

Official RxNorm record

Identity candidate · score 15.463016208261015

histamine dihydrochloride Topical Cream

Matched from: Histamine Dihydrochloride

Official RxNorm record

Identity candidate · score 16.811901092529297

RxNorm concept

Matched from: Histamine Dihydrochloride

Official RxNorm record

Identity candidate · score 15.65788407384133

histamine dihydrochloride Topical Cream [Australian Dream]

Matched from: MD SCIENCE CANNABIGEROL (LIDOCAINE AND HISTAMINE DIHYDROCHLORIDE) CREAM

Safety signals

Locally preserved FAERS reports

0reports

0reported as serious

FAERS/AEMS reports are post-market signals. Counts do not establish causality or incidence and may contain duplicates or reporting bias.

Sources and provenance

Official source snapshots

DailyMed structured labels

9dbcf5b8-8e9a-46f1-ba21-a37137813c32 · version 1

Retrieved 22/08/2026, 21:20:19Verify at source

Locally preserved regulatory fields

Related local records

Cannabinoids and active compounds

Condition reports

Approval, patents and exclusivity

Related registered studies

Indications in regulatory records

RxNorm candidates

RxNorm concept

histamine dihydrochloride / menthol Topical Cream [Alo]

histamine dihydrochloride / menthol Topical Product

histamine dihydrochloride Topical Cream

RxNorm concept

histamine dihydrochloride Topical Cream [Australian Dream]

Locally preserved FAERS reports

Official source snapshots

DailyMed structured labels

cannabidiol Oral Solution

Lidocaine

histamine dihydrochloride / menthol Topical Spray

capsaicin / histamine dihydrochloride Topical Product

histamine dihydrochloride Topical Spray

cannabidiol Oral Product

Cannabidiolic acid

cannabidiol Oral Liquid Product

cannabigerol

histamine dihydrochloride / menthol Topical Cream

histamine dihydrochloride Topical Product

capsaicin / histamine dihydrochloride Topical Cream

cannabigerolic acid

cannabigerolate

Lidocaine 37.8 mg in 1 mL / Histamine Dihydrochloride 0.041 mg in 1 mL TOPICAL CREAM [MD SCIENCE CANNABIGEROL]

RxNorm concept

capsaicin / histamine dihydrochloride / menthol Topical Cream

histamine dihydrochloride Topical Lotion

histamine dihydrochloride Topical Gel